vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and PARKE BANCORP, INC. (PKBK). Click either name above to swap in a different company.

Cryoport, Inc. is the larger business by last-quarter revenue ($45.5M vs $22.7M, roughly 2.0× PARKE BANCORP, INC.). PARKE BANCORP, INC. runs the higher net margin — 48.8% vs -17.5%, a 66.3% gap on every dollar of revenue. On growth, PARKE BANCORP, INC. posted the faster year-over-year revenue change (35.7% vs 9.6%). PARKE BANCORP, INC. produced more free cash flow last quarter ($39.0M vs $-4.5M). Over the past eight quarters, PARKE BANCORP, INC.'s revenue compounded faster (22.6% CAGR vs 10.4%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

Parke Bancorp, Inc. is a U.S. regional bank holding company operating Parke Bank. It offers commercial and retail banking services including deposit products, mortgage loans, small business financing and personal lending, primarily serving customers across New Jersey and the Philadelphia metropolitan area.

CYRX vs PKBK — Head-to-Head

Bigger by revenue
CYRX
CYRX
2.0× larger
CYRX
$45.5M
$22.7M
PKBK
Growing faster (revenue YoY)
PKBK
PKBK
+26.0% gap
PKBK
35.7%
9.6%
CYRX
Higher net margin
PKBK
PKBK
66.3% more per $
PKBK
48.8%
-17.5%
CYRX
More free cash flow
PKBK
PKBK
$43.5M more FCF
PKBK
$39.0M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
PKBK
PKBK
Annualised
PKBK
22.6%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYRX
CYRX
PKBK
PKBK
Revenue
$45.5M
$22.7M
Net Profit
$-8.0M
$11.1M
Gross Margin
47.8%
Operating Margin
-17.0%
64.2%
Net Margin
-17.5%
48.8%
Revenue YoY
9.6%
35.7%
Net Profit YoY
57.4%
49.8%
EPS (diluted)
$-0.19
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
PKBK
PKBK
Q4 25
$45.5M
$22.7M
Q3 25
$44.2M
$21.0M
Q2 25
$45.5M
$18.7M
Q1 25
$41.0M
$17.4M
Q4 24
$41.5M
$16.8M
Q3 24
$38.3M
$15.6M
Q2 24
$39.7M
$15.5M
Q1 24
$37.3M
$15.1M
Net Profit
CYRX
CYRX
PKBK
PKBK
Q4 25
$-8.0M
$11.1M
Q3 25
$-6.9M
$10.6M
Q2 25
$105.2M
$8.3M
Q1 25
$-12.0M
$7.8M
Q4 24
$-18.7M
$7.4M
Q3 24
$805.0K
$7.5M
Q2 24
$-78.0M
$6.5M
Q1 24
$-18.9M
$6.2M
Gross Margin
CYRX
CYRX
PKBK
PKBK
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CYRX
CYRX
PKBK
PKBK
Q4 25
-17.0%
64.2%
Q3 25
-22.5%
64.2%
Q2 25
-21.2%
59.0%
Q1 25
-23.1%
59.1%
Q4 24
-30.7%
58.0%
Q3 24
-34.9%
60.2%
Q2 24
-196.5%
56.7%
Q1 24
-46.9%
55.4%
Net Margin
CYRX
CYRX
PKBK
PKBK
Q4 25
-17.5%
48.8%
Q3 25
-15.7%
50.6%
Q2 25
231.4%
44.3%
Q1 25
-29.2%
44.6%
Q4 24
-45.1%
44.2%
Q3 24
2.1%
48.1%
Q2 24
-196.4%
41.6%
Q1 24
-50.7%
40.7%
EPS (diluted)
CYRX
CYRX
PKBK
PKBK
Q4 25
$-0.19
$0.93
Q3 25
$-0.18
$0.89
Q2 25
$2.05
$0.69
Q1 25
$-0.28
$0.65
Q4 24
$-0.42
$0.61
Q3 24
$-0.02
$0.62
Q2 24
$-1.62
$0.53
Q1 24
$-0.43
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
PKBK
PKBK
Cash + ST InvestmentsLiquidity on hand
$411.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$502.6M
$324.5M
Total Assets
$765.0M
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
PKBK
PKBK
Q4 25
$411.2M
Q3 25
$421.3M
Q2 25
$426.0M
Q1 25
$244.0M
Q4 24
$250.6M
Q3 24
$259.4M
Q2 24
$414.9M
Q1 24
$438.2M
Stockholders' Equity
CYRX
CYRX
PKBK
PKBK
Q4 25
$502.6M
$324.5M
Q3 25
$513.3M
$314.8M
Q2 25
$519.1M
$312.2M
Q1 25
$398.8M
$305.9M
Q4 24
$401.9M
$300.1M
Q3 24
$418.6M
$296.5M
Q2 24
$400.1M
$292.8M
Q1 24
$472.2M
$288.4M
Total Assets
CYRX
CYRX
PKBK
PKBK
Q4 25
$765.0M
$2.2B
Q3 25
$774.3M
$2.2B
Q2 25
$773.9M
$2.2B
Q1 25
$699.8M
$2.1B
Q4 24
$703.5M
$2.1B
Q3 24
$701.8M
$2.1B
Q2 24
$852.3M
$2.0B
Q1 24
$942.8M
$2.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
PKBK
PKBK
Operating Cash FlowLast quarter
$919.0K
$39.6M
Free Cash FlowOCF − Capex
$-4.5M
$39.0M
FCF MarginFCF / Revenue
-10.0%
171.3%
Capex IntensityCapex / Revenue
12.0%
2.6%
Cash ConversionOCF / Net Profit
3.57×
TTM Free Cash FlowTrailing 4 quarters
$-25.0M
$63.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
PKBK
PKBK
Q4 25
$919.0K
$39.6M
Q3 25
$2.2M
$11.4M
Q2 25
$-7.3M
$6.8M
Q1 25
$-4.3M
$7.0M
Q4 24
$-5.5M
$35.2M
Q3 24
$447.0K
$9.4M
Q2 24
$-8.0M
$8.9M
Q1 24
$-3.3M
$8.3M
Free Cash Flow
CYRX
CYRX
PKBK
PKBK
Q4 25
$-4.5M
$39.0M
Q3 25
$-1.3M
$11.2M
Q2 25
$-11.7M
$6.7M
Q1 25
$-7.5M
$6.6M
Q4 24
$-10.7M
$35.0M
Q3 24
$-3.8M
$9.4M
Q2 24
$-11.8M
$8.9M
Q1 24
$-7.3M
$8.3M
FCF Margin
CYRX
CYRX
PKBK
PKBK
Q4 25
-10.0%
171.3%
Q3 25
-2.9%
53.5%
Q2 25
-25.7%
35.8%
Q1 25
-18.3%
38.0%
Q4 24
-25.8%
209.1%
Q3 24
-9.9%
60.0%
Q2 24
-29.8%
57.1%
Q1 24
-19.5%
55.1%
Capex Intensity
CYRX
CYRX
PKBK
PKBK
Q4 25
12.0%
2.6%
Q3 25
7.8%
0.5%
Q2 25
9.6%
0.3%
Q1 25
7.7%
2.2%
Q4 24
12.6%
0.7%
Q3 24
11.1%
0.1%
Q2 24
9.5%
0.2%
Q1 24
10.7%
0.1%
Cash Conversion
CYRX
CYRX
PKBK
PKBK
Q4 25
3.57×
Q3 25
1.07×
Q2 25
-0.07×
0.82×
Q1 25
0.90×
Q4 24
4.75×
Q3 24
0.56×
1.25×
Q2 24
1.38×
Q1 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons